Research Article

HDL-C/apoA-I Ratio Is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome

Table 1

Baseline characteristics for non-DM and DM ACS patients.

CharacteristicsWhole ()Non-DM ()DM () value

Agens
Male, (%)365 (78.00)249 (79.30)116 (75.32)ns
BMI (kg/m2)ns
Current smoker, (%)135 (28.8)93 (29.62)42 (27.27)ns
Family history of CAD, (%)183 (39.10)129 (41.08)54 (35.06)ns
Hypertension, (%)255 (54.5)166 (52.87)89 (57.79)ns
Heart rate (bpm)ns
Systolic BP (mmHg)ns
Diastolic BP (mmHg)ns
LVEF (%)ns
Affected vessels<0.05
BUNns
Creatine (μmol/L)ns
hsCRP (mg/dL)ns
HDL-C (mmol/L)ns
LDL-C (mmol/L)ns
Triglyceride (mmol/L)ns
Lipoprotein A (mg/L)ns
apoA-I (g/L)ns
HbA1c (%)<0.001
HDL-C/apoA-I (mmol/g)<0.01
Medication at discharge
 Aspirin, (%)462 (98.7)309 (98.4)153 (99.4)ns
 Clopidogrel, (%)448 (95.7)300 (95.5)148 (96.1)ns
 Statin, (%)459 (98.1)309 (98.4)150 (97.4)ns
 ACEI/ARB, (%)417 (89.1)278 (88.5)139 (90.3)ns
 Beta-blockers, (%)410 (87.6)276 (87.9)134 (87.0)ns
 CCB, (%)102 (21.8)68 (21.7)34 (22.1)ns
Main diagnosis
 UA229 (48.9)150 (47.77)79 (51.30)ns
 NSTEMI71 (15.2)50 (15.92)21 (13.64)ns
 STEMI168 (35.9)114 (36.31)54 (35.06)ns

Data are and number (%). ACS: acute coronary syndrome; ACEI: angiotensin-converting enzyme inhibitor; apoA-I: apolipoprotein A-I; ARB: angiotensin receptor blocker; BMI: body mass index; BP: blood pressure; BUN: blood urea nitrogen; CAD: coronary artery disease; CCB: calcium channel blocker; CKMB: creatine kinase MB; DM: diabetes mellitus; HbA1c: hemoglobin A1c; HDL-C: high-density lipoprotein cholesterol; hsCRP: high-sensitivity C-reactive protein; LDL-C: low-density lipoprotein cholesterol; LVEF: left ventricular ejection fraction; NSTEMI: non-ST elevated myocardial infarction; STEMI: ST elevated myocardial infarction; UA: unstable angina.